Emmaus Life Sciences EMMA
OTC EMMA
$0.05 -0.01 (-16.67%)
At close: Oct 19, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Acquisitions (2017 - 2019)

Updated

Emmaus Life Sciences (EMMA) reported Acquisitions of $4,000 for Q4 2019.

Analysis

Emmaus Life Sciences (EMMA) Acquisitions (2017 - 2019) Analysis & Trends

For FY2019, Emmaus Life Sciences posted Acquisitions of $1.65 million.

  • By year, Acquisitions came in at $306,600 in FY2018.
  • The Q4 2019 figure ranks as the lowest quarterly Acquisitions since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Emmaus Life Sciences 3.51 Mn -2.79 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 4,000.00
Sep 30, 2018 157,500.00
Jun 30, 2018 -157,500.00
Dec 31, 2017 306,600.00
API Access

Emmaus Life Sciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=EMMA&period=max&api_key=YOUR_API_KEY